423 POSTER Phase I dose escalation study of NK012, polymer micelle of irinotecan metabolite SN-38, in patients with advanced cancer

D.Toshihiko; N.Fuse; A.Ohtsu; Y.Matsumura; T.Hamaguchi; K.Kato; Y.Shimada; T.Nakajima; Y.Yamada; M.Takanashi

首页> 外文期刊>European Journal of Cancer Supplements >423 POSTER Phase I dose escalation study of NK012, polymer micelle of irinotecan metabolite SN-38, in patients with advanced cancer

【24h】

423 POSTER Phase I dose escalation study of NK012, polymer micelle of irinotecan metabolite SN-38, in patients with advanced cancer

机译：423 POSTER晚期癌症患者NK012（伊立替康代谢产物SN-38的聚合物胶束）的I期剂量递增研究

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2008年第12期|共1页
作者
D.Toshihiko; N.Fuse; A.Ohtsu; Y.Matsumura; T.Hamaguchi; K.Kato; Y.Shimada; T.Nakajima; Y.Yamada; M.Takanashi;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. A phase I dose escalation study of NK012, an SN-38 incorporating macromolecular polymeric micelle [J] . Burris Howard A., Infante Jeffrey R., Greco F. Anthony, Cancer chemotherapy and pharmacology. . 2016,第5期

机译：掺入高分子高分子胶束的SN-38 NK012的I期剂量递增研究
2. A phase II study of NK012, a polymeric micelle formulation of SN-38, in unresectable, metastatic or recurrent colorectal cancer patients [J] . Tetsuya Hamaguchi, Akihito Tsuji, Kensei Yamaguchi, Cancer chemotherapy and pharmacology. . 2018,第6期

机译：NK012的II期研究，SN-38的聚合物胶束制剂，在不可切除，转移性或复发结直肠癌患者中
3. 1474 POSTER A phase I, open-label study with escalating doses of intravenous PTK787/ZK 222584, a multi-VEGF receptor inhibitor, followed by multiple oral daily dosing to assess the absolute bioavailability of PTK787/ZK 222584 after single and multiple doses in advanced cancer patients [J] . European Journal of Cancer Supplements . 2005,第2期

机译：1474 POSTER A阶段I，开放标签研究，逐步增加剂量的静脉内PTK787 / ZK 222584（一种多VEGF受体抑制剂），然后每天多次口服给药，以评估晚期单次和多次给药后PTK787 / ZK 222584的绝对生物利用度癌症病人
4. Nano-Sized Drug Carrier for Cancer Therapy: Dose-Toxicity Relationship of PEG-PCL-PEG Polymeric Micelle on ICR Mice [C] . J.L. Jiang, N.V. Cuong, S.C. Jwo, 12th Mediterranean conference on medical and biological engineering and computing 2010 . 2010

机译：用于癌症治疗的纳米级药物载体：PEG-PCL-PEG聚合物胶束对ICR小鼠的剂量-毒性关系
5. A phase I study of vincristine, escalating doses of irinotecan, temozolomide and bevacizumab (VIT-B) in pediatric and adolescent patients with recurrent or refractory solid tumors of non-hematopoietic origin [D] . Venkatramani, Rajkumar. 2010

机译：长春新碱，伊非替康，替莫唑胺和贝伐单抗（VIT-B）逐步剂量在患有非造血源性复发或难治性实体瘤的儿童和青少年患者中的I期研究
6. A phase II study of NK012 a polymeric micelle formulation of SN-38 in unresectable metastatic or recurrent colorectal cancer patients [O] . Tetsuya Hamaguchi, Akihito Tsuji, Kensei Yamaguchi, -1

机译：NK012是SN-38的聚合物胶束制剂的II期研究用于不可切除转移或复发的结直肠癌患者
7. A phase II study of NK012, a polymeric micelle formulation of SN-38, in unresectable, metastatic or recurrent colorectal cancer patients [O] . Tetsuya Hamaguchi, Akihito Tsuji, Kensei Yamaguchi, 2018

机译：NK012的II期研究，SN-38的聚合物胶束制剂，在不可切除，转移性或复发结直肠癌患者中

423 POSTER Phase I dose escalation study of NK012, polymer micelle of irinotecan metabolite SN-38, in patients with advanced cancer

著录项

相似文献

相关主题

期刊订阅